Resources and Reference materials

Featured Publications

Simultaneous quantification of SMN1 and SMN2 copy numbers by MALDI-TOF mass spectrometry for spinal muscular atrophy genetic testing

Hereditary Genetics , , 2022

Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS

Infectious Disease , , 2022

RT-PCR and Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry Diagnostic Target Performance Reflects Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variant Diversity in New York City

Infectious Disease , , 2022

Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel

Liquid Biopsy , , 2022

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) including Variant Analysis by Mass Spectrometry in Placental Tissue

Infectious Disease , , 2022

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

PGx , , 2022

View All Publications

Latest Videos & Webinars

CFTR,

Webinar: Using the MassARRAY System to Perform Population-based Newborn Screening for Cystic Fibrosis

PGx,

Webinar: Recent Developments in PGx – Predictive Biomarker Identification and Relevance

Oncology,

Webinar: Detection of Somatic Variants in Breast Cancer Specimens Using the ClearSEEK PIK3CA Panel

Featured Publications

Simultaneous quantification of SMN1 and SMN2 copy numbers by MALDI-TOF mass spectrometry for spinal muscular atrophy genetic testing

Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS

RT-PCR and Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry Diagnostic Target Performance Reflects Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variant Diversity in New York City

Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) including Variant Analysis by Mass Spectrometry in Placental Tissue

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

Featured Product Literature

MassARRAY^® System Brochure

SARS-CoV-2 (EUA) Panel Product Sheet

Oncology Solutions Brochure

Need Support?

Learning Center

Latest Videos & Webinars

CFTR,

Webinar: Using the MassARRAY System to Perform Population-based Newborn Screening for Cystic Fibrosis

PGx,

Webinar: Recent Developments in PGx – Predictive Biomarker Identification and Relevance

Oncology,

Webinar: Detection of Somatic Variants in Breast Cancer Specimens Using the ClearSEEK PIK3CA Panel

Featured Publications

Simultaneous quantification of SMN1 and SMN2 copy numbers by MALDI-TOF mass spectrometry for spinal muscular atrophy genetic testing

Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS

RT-PCR and Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry Diagnostic Target Performance Reflects Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variant Diversity in New York City

Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) including Variant Analysis by Mass Spectrometry in Placental Tissue

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

Featured Product Literature

MassARRAY® System Brochure

SARS-CoV-2 (EUA) Panel Product Sheet

Oncology Solutions Brochure

Need Support?

MassARRAY^® System Brochure